Full-Time
Posted on 3/10/2025
No salary listed
Junior, Mid
Jackson, MS, USA
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Mountain View, California
Founded
1992
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Paid Vacation
Matt Manning, Sr. Director of Operations for Health Systems at OmnicellTo meet the rising demand for drugs to treat rare and chronic conditions, the industry’s largest players (e.g., CVS Health, Cigna, and UnitedHealth Group) have moved quickly to derive two-thirds of their prescription revenues from specialty dispensing. Health systems are following suit, rapidly launching entity-owned specialty pharmacies that enable these providers to strengthen the continuity of care they deliver to patients. As providers stake out claim in the competitive $68.3 billion specialty drug market, strategic application of data analytics to provide key fulfillment insights could be the differentiator that ensures success.Challenges Associated with Entity-Owned Specialty PharmaciesA fully optimized, entity-owned specialty pharmacy is a key way for health systems to improve patient care by increasing access to specialty medications and reducing the turnaround time for prescription fulfillment while at the same time generating revenue via increased script capture. However, challenges in key operational areas prevent health systems from realizing these benefits, including:Interoperability: As seamless data exchange remains the modern healthcare standard. Pharmacies with connectivity gaps suffer hits to patient experience and care coordination due to not having the most up-to-date information to influence patient onboarding, prescribing decisions, and patient communications.As seamless data exchange remains the modern healthcare standard
Omnicell to Release Fourth Quarter and Full Year 2024 Financial Results on February 6, 2025
After scaling the company to 50 staff and annual revenues exceeding $10 million, Avantec was acquired by Omnicell (NASDAQ: OMCL) in 2015.
Omnicell, an innovator in pharmacy and nursing care, has introduced OmniSphere, a cloud-native software workflow engine and data platform that is the next iteration.
FARMINGTON HILLS, Mich., Dec. 4, 2024 /PRNewswire/ -- LSPedia, a leading provider of traceability and compliance solutions for the pharmaceutical industry, today announced a collaboration with Omnicell, Inc., a leader in transforming the pharmacy care delivery model, that aims to streamline pharmaceutical supply chain operations and strengthen compliance with regulatory standards such as the Drug Supply Chain Security Act (DSCSA). LSpedia and Omnicell have developed a solution that is designed to integrate LSPedia's OneScan® traceability and compliance platform with Omnicell's Central Pharmacy Manager software, that is intended to help empower healthcare providers to achieve end-to-end visibility and control in the supply chain receiving process, which should help reduce costs, support DSCSA compliance, and mitigate risks associated with counterfeit drugs. Benefits of the DSCSA interface include: Enhanced Compliance: Automated serialization and traceability capabilities that are intended to support DSCSA compliance